GENERAL COMMENTS
The authors present a very interesting protocol on the effects of vitamin D supplementation on bone density in vitamin D deficient children. Strengths of this paper are the extensive analyses that aim to determine whether the effect of vitamin D supplementation on bone density in children by summarizing several randomized controlled trials. However, some major issues need to be further addressed.
Major comments 1.Page 5, Line 37: The abbreviation of BMC need to be fully addressed at the first appeared. Also, page 6. Line 48, the explanation of individual participant data (IPD) should move to the first appeared. 2. In the introduction parts, the authors fully described the significance of peak bone mass, however, the relationship between vitamin D and peak bone mas, and the status and risk of children vitamin D deficiency were less described. The anthers need to strength the background. 3. In the eligibility criteria part, it is better to list the exclusion criteria after the inclusion criteria.
4. According to the WHO's children definition, children refer to whose who under 18 years old, while in the types of participants, adolescents (aged < 20 years) were also selected. Please identify the age border. 5. The relationship between peak bone mass and children's age should be explained in the introduction part and also sensitivity analysis should be conducted in the statistical analysis part, dividing groups by age, such as preschool children, primary school children and adolescents. 6. In the types of outcome measures part, since the IPD metaanalysis aims to determine whether the effect of vitamin D supplementation on bone density in children differs according to baseline vitamin D status, and specifically estimate the effect of vitamin D in children who are vitamin D deficient, the authors should differentiate various outcomes, and identify the primary outcomes and secondary outcomes.
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GENERAL COMMENTS
The study design is adequated and the issue is very important
VERSION 1 -AUTHOR RESPONSE
Thanks the reviewers for the comments. We have made responses and all changes are tracked. 1. Page 5, Line 37: The abbreviation of BMC need to be fully addressed at the first appeared. Also, page 6. Line 48, the explanation of individual participant data (IPD) should move to the first appeared. Response: They have been corrected (see abstract and main text, page 6 and 7).
